Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data

• Main Authors: Chengcheng Gong (Author), Yizhao Xie (Author), Yannan Zhao (Author), Yi Li (Author), Jian Zhang (Author), Leiping Wang (Author), Jun Cao (Author), Zhonghua Tao (Author), Xichun Hu (Author), Biyun Wang (Author)
• Format: Book
• Published: SAGE Publishing, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: Weekly gemcitabine + paclitaxel (wGT) administration is widely applied in real-world clinical practice. The 28-day and 21-day regimens of wGT are the most widely accepted regimens. We evaluated the efficacy and safety of wGT administration in patients with metastatic breast cancer (MBC) and...